Table 1 Clinical and demographic... | American Society of Hematology

Table 1

Clinical and demographic characteristics of study patients

	No. of patients	Age, y	Time since diagnosis, mo	CD4 cell count/ μL	Viral load, copies/mL	HIV-1 epitope tested									EBV/CMV epitope tested
	No. of patients	Age, y	Time since diagnosis, mo	CD4 cell count/ μL	Viral load, copies/mL	No.	A2IV9	A2SL9	A3QK10	B8EI8	B8FL8	B27KK10	B57KF11	B57TW10	No.	A2-NV9 (CMV)	B8-FL8 (EBV)
Progressor	13	46	36	526	143 000	14	0	5	1	4	1	2	1	0	11	7	4
Controller	9	43	182.5	596	82	14	2	3	0	5	4	0	0	0	9	4	5
Acute	6	43.5	2	747	196 300	7	0	0	0	0	4	1	1	1	0	0	0

	No. of patients	Age, y	Time since diagnosis, mo	CD4 cell count/ μL	Viral load, copies/mL	HIV-1 epitope tested									EBV/CMV epitope tested
	No. of patients	Age, y	Time since diagnosis, mo	CD4 cell count/ μL	Viral load, copies/mL	No.	A2IV9	A2SL9	A3QK10	B8EI8	B8FL8	B27KK10	B57KF11	B57TW10	No.	A2-NV9 (CMV)	B8-FL8 (EBV)
Progressor	13	46	36	526	143 000	14	0	5	1	4	1	2	1	0	11	7	4
Controller	9	43	182.5	596	82	14	2	3	0	5	4	0	0	0	9	4	5
Acute	6	43.5	2	747	196 300	7	0	0	0	0	4	1	1	1	0	0	0